Trials / Completed
CompletedNCT04070742
Dermal Phototoxicity Study
A 4-Day, Randomized, Controlled Study to Evaluate the Phototoxicity Potential of FMX-101, 4% in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Vyne Therapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Dermal Safety study to determine the Phototoxicity Potential of FMX-101 4% in Healthy Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FMX101 |
Timeline
- Start date
- 2016-08-17
- Primary completion
- 2016-09-07
- Completion
- 2016-10-01
- First posted
- 2019-08-28
- Last updated
- 2019-09-11
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04070742. Inclusion in this directory is not an endorsement.